期刊文献+

402例烟雾病抗核抗体谱检测结果分析

Analysis of the Results of Antinuclear Antibody Spectrum for Patients of Moyamoya
下载PDF
导出
摘要 目的:探讨烟雾病的发生与自身免疫性疾病是否存在一定的联系。方法:对402例烟雾病抗核抗体谱检测结果进行回顾性分析。结果:402例烟雾病确诊病例中,有112位患者抗核抗体谱检测结果中存在阳性结果,阳性率为27.86%。其中,抗dsDNA、抗CB、抗Sm、抗SS-A、抗SS-B、抗Jo-1、抗RO-52、抗ScL-70、抗RIB、抗PM-sd、抗nRNP、抗PCNA、抗Nuc、抗HI、抗M2抗体在阳性病例中所占百分比分别为16.07%、1.79%、5.36%、17.86%、7.14%、5.36%、13.39%、5.36%、7.14%、4.46%、2.68%、11.61%、6.25%、8.93%和8.04%。结论:烟雾病患者中抗核抗体阳性率较高,自身免疫性疾病可能是烟雾病发生的重要诱因之一。 Objective: Look for the occurrence of moyamoya disease with autoimmune diseases was the existence of certain links.Methods: 402 cases of moyamoya disease spectrum antinuclear antibody test results were analyzed respectively.Results: 112 cases of anti-nuclear antibody spectrum result was positive in 402 cases of moyamoya disease,the positive rate was 27.86%,and the percentage of anti-dsDNA,anti-CB,anti-Sm,anti-SS-A,anti SS-B,anti Jo-1,anti-RO-52,anti-ScL-70,anti-RIB,anti-PM-sd,anti-nRNP,anti-PCNA,anti-Nuc,anti-HI and anti-M2 antibodies were 16.07%,1.79%,5.36%,17.86%,7.14%,5.36%,13.39%,5.36%,7.14%,4.46%,2.68%,11.61%,6.25% and 8.93%,8.04%,respectively.Conclusion: Autoimmune disease may be one of the causes of moyamoya disease.
出处 《生物技术通讯》 CAS 2011年第5期723-725,共3页 Letters in Biotechnology
关键词 烟雾病 抗核抗体 自身免疫性疾病 moyamoya disease antinuclear antibody spectrum autoimmune diseases
  • 相关文献

参考文献4

二级参考文献12

  • 1[1]Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiogical features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg, 1997, 99(Suppl) 2: 1-5.
  • 2[2]Goto F, Yonekawa Y. World wide distribution of moyamoya disease. Neurol Med Chir, 1992, 32: 883-886.
  • 3[3]Kawano T, Fukui M, Hashimoto N, et al. Follow-up study of patients with "unilateral" moyamoya disease. Neurol Med Chir, 1994, 34: 744-747.
  • 4[4]Tanigawara T, Yamada H, Sakai N, et al. Studies on cytomegalovirus and Epstein-Bair virus infection in moyamoya disease. Clin Neurol Neurosurg, 1997, 99 (Suppl 2):225-228.
  • 5[5]Yashimoto T, Houkin K, Takahashi A, et al. A ngiogenic factors in moyamoya disease. Stroke, 1996, 27: 2160-2165.
  • 6[6]Inoue TK, Ikezaki K, Sasazuki T, et al. Analysis of class Ⅱ genes of human leukocyte antigen in patients with moyamoya diseases. Clin Neurol Neuro surg, 1997,99 (Suppl 2) :234-237.
  • 7[7]Moch H, Schraml P, Bubendorf L, et al. High throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinomal. Am J Pathol, 1999, 154: 981-986.
  • 8[8]Wang K, Can L, Jeffery E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene, 1999, 229: 101-108.
  • 9刘敏,冯柏庄,俞纯山.系统性红斑狼疮患者自身抗体检测方法的应用与评价[J].陕西医学检验,1997,12(1):3-5. 被引量:49
  • 10许玲玲,刘敏,俞纯山.系统性红斑狼疮患者4种抗体检测的临床意义[J].江西医学检验,1999,17(2):98-99. 被引量:3

共引文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部